You can buy or sell Biofrontera and other stocks, options, and ETFs commission-free!
Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany. The listed name for BFRA is Biofrontera AG American Depositary Shares.
52 Week High
52 Week Low
— per share
Expected Apr 19